Flagship explainer
What drives PHATHOM PHARMACEUTICALS, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$221M | FY2025 |
| |
| Income before tax | −$221M | FY2025 |
|
| Operating income | −$160M | FY2025 |
|
| $175M | FY2025 |
| |
| Ending assets | $259M | FY2025 |
|
| Beginning assets | $378M | FY2024 |
|
| −$438M | FY2025 |
| |
| −$254M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001193125-26-073379